SUBSCRIBE
SUBSCRIBE

Global Blood Therapeutics

NEWS
Global Blood Therapeutics was acquired by Pfizer in August 2022.
Woman celebrating her goals. Successful concept.
Drug Development
A Roundup of Some of This Week’s Clinical Trial Successes!
This week had a few disappointing clinical trials, as do most weeks, but it also had a number of significant successes. Here’s a look at some of the clinical trials that met their primary endpoints this week.
June 29, 2018
 · 
5 min read
 · 
Mark Terry
Drug Development
GBT’s Sickle Cell Drug Shows Promise in Phase III Trial
Global Blood Therapeutics (GBT) reported the results of a review of Part A of its Phase III HOPE (Hemoglobin Oxygen Affinity Modulation to Inhibit HbS PolymErization) Study of voxelotor for sickle cell disease.
June 27, 2018
 · 
3 min read
 · 
Mark Terry
Deals
Who are the Top 3 Biotech Takeover Targets?
Most investors thought 2018 would be a big year for mergers and acquisitions in the biopharma industry because of changes to the tax law, and so far they’ve been right.
May 22, 2018
 · 
3 min read
 · 
Mark Terry
Ignyta Stock Booms on Promising Mid-Stage Lung Can
Drug Development
Bay Area’s Global Blood Therapeutics Terminates Lung Disease Program
The company is shuttering its GBT440 program to treat idiopathic pulmonary fibrosis (IPF).
October 23, 2017
 · 
2 min read
 · 
Mark Terry
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Bay Area’s Global Blood Therapeutics, Aimmune Jump on the IPO Wagon Seeking $115 Million Each
July 10, 2015
 · 
3 min read
Load More
AWARDS
  • NextGen Class of 2015
JOBS
IN THE PRESS
Biotech Bay
GBT Announces Participation at the Goldman Sachs 42nd Annual Global Healthcare Conference
June 1, 2021
 · 
1 min read
Biotech Bay
GBT Announces Upcoming Data Presentations at European Hematology Association (EHA) 2021 Virtual Congress
May 12, 2021
 · 
13 min read
Biotech Bay
GBT Announces Participation in Upcoming Investor Conferences - May 06, 2021
May 6, 2021
 · 
1 min read
Business
GBT Reports First Quarter 2021 Financial Results
May 5, 2021
 · 
19 min read
BioCapital
GBT and Sickle Cell Disease Association of America Kick Off “Lift Every Voice to Shine the Light on Sickle Cell” Spoken Word Contest in Honor of World Sickle Cell Day 2021
May 4, 2021
 · 
5 min read
Business
GBT to Announce First Quarter 2021 Financial Results on Wednesday, May 5, 2021
April 28, 2021
 · 
1 min read
Drug Development
Complete 72-Week Results from Phase 3 HOPE Study of Oxbryta® (voxelotor) Tablets Published in The Lancet Haematology Show Significantly Improved Hemoglobin, Hemolysis and Overall Health Status in Sickle Cell Disease Patients
April 8, 2021
 · 
13 min read
Deals
GBT Announces New Employment Inducement Grants - Apr 05, 2021
April 5, 2021
 · 
1 min read
Business
GBT Appoints Alexis A. Thompson, M.D., M.P.H., to Board of Directors
March 18, 2021
 · 
8 min read
Business
GBT Expands Sickle Cell Disease Pipeline with Exclusive In-license of Two Novel Small Molecule Programs from Sanofi S.A.
March 16, 2021
 · 
7 min read
Load More